Peter Dreger Selected Research

Peter Dreger Research Topics

Disease

46	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2022 - 03/2003
35	Neoplasms (Cancer) 05/2022 - 06/2003
32	Lymphoma (Lymphomas) 01/2022 - 06/2003
24	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022 - 09/2006
15	Leukemia 01/2021 - 10/2004
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2022 - 06/2003
12	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022 - 12/2015
12	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 01/2009
11	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 06/2003
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021 - 01/2009
10	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 03/2006
8	Residual Neoplasm 01/2022 - 10/2004
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 10/2015
8	Multiple Myeloma 10/2020 - 06/2006
7	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 04/2004
6	Infections 06/2022 - 06/2014
5	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 04/2009
4	Bronchiolitis Obliterans Syndrome 10/2021 - 01/2012
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2021 - 10/2016
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 12/2008
3	Weight Loss (Weight Reduction) 02/2022 - 05/2015
3	COVID-19 02/2022 - 10/2020
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 06/2014
3	Disease Progression 01/2020 - 06/2018
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019 - 01/2008
2	Sepsis (Septicemia) 01/2022 - 10/2013
2	Pathologic Complete Response 11/2019 - 04/2004
2	Aplastic Anemia (Anemia, Hypoplastic) 06/2019 - 01/2019
2	Thrombotic Microangiopathies 10/2018 - 09/2017
2	Fatigue 10/2016 - 09/2015
2	Amyloidosis 01/2016 - 03/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 06/2014
2	Thrombocytosis (Thrombocythemia) 07/2012 - 12/2009
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 06/2010 - 05/2007
1	Plasma Cell Leukemia 06/2022
1	Atrophy 04/2022
1	Muscular Atrophy (Muscle Atrophy) 04/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Cytokine Release Syndrome 01/2022
1	cell-associated neurotoxicity 01/2022
1	Fibrosis (Cirrhosis) 10/2021
1	Encephalitis (Encephalitis, Rasmussen) 10/2021

Drug/Important Bio-Agent (IBA)

21	Chimeric Antigen ReceptorsIBA 11/2022 - 10/2016
12	Rituximab (Mabthera)FDA Link 01/2021 - 01/2007
10	SteroidsIBA 01/2022 - 08/2011
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2012
7	fludarabineIBA 01/2021 - 04/2004
5	idelalisibIBA 02/2022 - 01/2019
4	ibrutinibIBA 01/2022 - 01/2019
4	Busulfan (Busulfex)FDA Link 01/2022 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
3	axicabtagene ciloleucelIBA 11/2022 - 10/2021
3	purineIBA 11/2019 - 12/2014
3	Brentuximab VedotinIBA 01/2019 - 11/2012
2	obinutuzumabIBA 04/2022 - 01/2022
2	LeptinIBA 02/2022 - 05/2015
2	venetoclaxIBA 01/2022 - 01/2020
2	treosulfanIBA 01/2022 - 01/2020
2	CytokinesIBA 10/2021 - 12/2020
2	AntigensIBA 07/2021 - 06/2006
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 12/2018
2	PlatinumIBA 01/2021 - 04/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018 - 03/2014
2	serum P-component (CIt)IBA 06/2018 - 01/2018
2	Vitamin D FDA LinkGeneric 09/2017 - 01/2017
2	Azacitidine (5 Azacytidine)FDA Link 01/2017 - 08/2014
2	ThrombomodulinIBA 10/2014 - 11/2012
2	Alemtuzumab (Campath)FDA Link 08/2009 - 09/2006
2	Peptides (Polypeptides)IBA 06/2006 - 06/2003
2	Immunoglobulins (Immunoglobulin)IBA 10/2004 - 03/2003
1	tisagenlecleucelIBA 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	GlucocorticoidsIBA 04/2022
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 04/2022
1	tirabrutinibIBA 04/2022
1	Bispecific AntibodiesIBA 12/2021
1	KynurenineIBA 10/2021
1	Kynurenic Acid (Kynurenate)IBA 10/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	polatuzumab vedotinIBA 01/2021

Therapy/Procedure

90	Stem Cell Transplantation 02/2022 - 03/2003
44	Therapeutics 11/2022 - 04/2004
34	Transplantation 01/2021 - 04/2004
28	Cell Transplantation 06/2022 - 01/2008
24	Hematopoietic Stem Cell Transplantation 04/2022 - 11/2008
15	Drug Therapy (Chemotherapy) 01/2022 - 04/2004
9	Homologous Transplantation 02/2022 - 11/2007
8	Immunotherapy 01/2022 - 06/2018
5	Autologous Transplantation 05/2019 - 04/2004
3	Photopheresis 01/2022 - 01/2018
3	Salvage Therapy 01/2020 - 06/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2012
2	Haploidentical Transplantation 01/2019 - 10/2017
1	Resistance Training 04/2022
1	Nutritional Support (Artificial Feeding) 04/2022
1	Molecular Targeted Therapy 06/2021